Portfolio

By the Numbers

In eight years, MaRS Innovation’s team has assessed 1,500 disclosures, created 60 companies and taken an additional 100 technologies under management.

Of our companies, 52 are growing in Canada. Collectively, they’ve attracted $160 million in external investment with $95 million coming from outside of Canada, and have created over 400 direct jobs.

Angel investors and venture firms investing in our portfolio hail from China, Germany, Hong Kong, the Kingdom of Saudi Arabia, the Netherlands, the United Kingdom and the United States.

Our industry partners include Baxter, GSK, Johnson & Johnson, LifeLabs, Merck, Pfizer and TandemLaunch.

Portfolio Companies and Technologies

Type

Member

Sector

Development Stage

UTEST

  • Anxiety Meter for Children with Autism Spectrum Disorder
  • Appulse Power
  • Ardra
  • Bedside Clinical Systems (BCS)
  • Bio-manufacturing technology
  • Blood Test for Depression
  • Blue J Legal
  • BlueDot
  • BresoTEC
  • ChipCare
  • Computer Vision Technology
  • Conductive Polymer Nanocomposites
  • Conference Cloud
  • CoursePeer
  • Crowdmark
  • DashMD
  • Deep Genomics
  • Emergency Heart Failure Mortality Risk Grade
  • Encycle Therapeutics
  • eQOL
  • FlowJEM
  • Flybits Inc.
  • Formation Biologics
  • Gene42
  • Granata Decision Systems
  • Hammock Therapeutics
  • High-Efficiency, High-Power Ultrasound Transducer
  • Kapplex Inc.
  • Kaypok Inc.
  • Knitt Labs
  • LegUp Acceleration Solutions
  • LegWorks
  • Nuralogix
  • Nvest
  • OtoSim Inc
  • Precision tool for sharing segmented big data
  • PrintEm
  • QD Solar
  • Radialis Medical
  • ScarX Therapeutics
  • Thotra
  • Tigecycline
  • Treata Smart Solutions
  • TrendMD
  • Triphase Accelerator
  • Ultrasound-Based Radiotherapy Treatment Monitoring
  • UT Speech Recognition
  • Vasomune Logo
    Vasomune Therapeutics
  • VitalHub
  • WaveCheck
  • Whirlscape Logo
    Whirlscape
  • Xagenic
  • XLV Diagnostics
  • XOR Labs Toronto
  • Zucara Therapeutics